URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Thomas Watson

Concepts (215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Esophageal Neoplasms
17
2004
76
4.780
Why?
Esophageal Diseases
7
1997
21
3.010
Why?
Adenocarcinoma
11
2007
431
2.710
Why?
Esophagectomy
14
1997
33
2.700
Why?
Barrett Esophagus
9
2004
24
2.670
Why?
Esophagoscopy
9
2005
28
2.570
Why?
Precancerous Conditions
3
2008
36
1.890
Why?
Gastroesophageal Reflux
6
1998
29
1.570
Why?
Esophagus
9
2007
69
1.380
Why?
Digestive System Surgical Procedures
2
2009
23
1.280
Why?
Lymph Nodes
3
2002
207
0.900
Why?
Fundoplication
3
2005
16
0.840
Why?
Trachea
2
2005
67
0.830
Why?
Mediastinum
2
2009
18
0.770
Why?
Bronchoscopy
1
2010
27
0.730
Why?
Stomach
5
1997
70
0.720
Why?
Deglutition
2
2009
13
0.700
Why?
Humans
47
1996
35000
0.690
Why?
Neoplasm Recurrence, Local
2
2008
272
0.680
Why?
Hernia, Hiatal
4
2009
12
0.680
Why?
Catheter Ablation
2
2009
72
0.660
Why?
Treatment Outcome
13
1996
2487
0.640
Why?
Homeodomain Proteins
4
2007
100
0.570
Why?
Robotics
1
2008
76
0.560
Why?
Patient Selection
6
1996
197
0.540
Why?
Manometry
4
2005
16
0.540
Why?
Esophagogastric Junction
1
2005
8
0.510
Why?
Polymethyl Methacrylate
1
2005
15
0.510
Why?
Lung Neoplasms
5
2002
422
0.510
Why?
Lung
2
1996
1132
0.480
Why?
Male
32
1998
18870
0.480
Why?
Hydrogen-Ion Concentration
2
2005
561
0.480
Why?
Thoracic Surgery
1
2004
14
0.470
Why?
Preoperative Care
1
2005
124
0.470
Why?
Bile Acids and Salts
3
2007
21
0.460
Why?
Lymphatic Metastasis
6
2002
137
0.420
Why?
Female
27
1998
19061
0.400
Why?
Aged
21
1998
6986
0.390
Why?
Jejunum
2
1997
53
0.380
Why?
Sensitivity and Specificity
4
2002
866
0.380
Why?
Colon
2
1997
74
0.370
Why?
Esophageal pH Monitoring
2
2009
4
0.360
Why?
Middle Aged
22
1998
9461
0.360
Why?
Surgical Procedures, Minimally Invasive
2
2008
30
0.340
Why?
Neoplasm Staging
6
2008
326
0.330
Why?
Diagnostic Techniques, Digestive System
2
2009
6
0.330
Why?
Radiation-Sensitizing Agents
2
2007
72
0.320
Why?
Follow-Up Studies
6
1998
1757
0.310
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
66
0.310
Why?
Risk Assessment
3
2005
808
0.300
Why?
Mucins
2
2007
26
0.290
Why?
Reconstructive Surgical Procedures
1
1998
81
0.290
Why?
Prognosis
3
2008
1030
0.280
Why?
Aged, 80 and over
11
2002
2423
0.280
Why?
Lung Transplantation
1
1996
10
0.270
Why?
Intestines
2
2007
153
0.270
Why?
Anastomosis, Surgical
3
1998
64
0.260
Why?
Peristalsis
2
2011
4
0.240
Why?
Clinical Trials as Topic
2
2008
664
0.240
Why?
Bronchi
2
1996
91
0.240
Why?
Survival Analysis
4
2008
575
0.240
Why?
Neoplasm Invasiveness
3
2009
150
0.230
Why?
Predictive Value of Tests
3
2009
579
0.230
Why?
RNA, Messenger
4
2007
1791
0.230
Why?
Deglutition Disorders
2
1998
20
0.230
Why?
Postoperative Complications
5
2007
706
0.220
Why?
Adult
14
1998
10906
0.220
Why?
Severity of Illness Index
3
2005
878
0.220
Why?
Emergencies
2
2009
78
0.210
Why?
Nucleosides
1
2012
11
0.210
Why?
Quantum Theory
1
2012
13
0.200
Why?
Deoxycholic Acid
2
2008
7
0.200
Why?
Population Surveillance
2
2009
120
0.200
Why?
Tomography, X-Ray Computed
2
2002
729
0.200
Why?
Electric Impedance
1
2011
15
0.200
Why?
Retrospective Studies
6
1998
2167
0.190
Why?
Registries
2
2009
203
0.190
Why?
Esophageal Achalasia
1
2011
4
0.190
Why?
Endoscopy
1
2011
81
0.190
Why?
Cancer Care Facilities
1
2010
10
0.180
Why?
Endosonography
1
2010
14
0.180
Why?
Stents
1
2011
124
0.180
Why?
Taxoids
1
2010
14
0.180
Why?
Length of Stay
2
2008
284
0.170
Why?
Surgical Procedures, Elective
1
2009
32
0.170
Why?
Laparoscopy
1
2012
187
0.170
Why?
Lymph Node Excision
1
2010
45
0.170
Why?
Carcinoma
1
2011
188
0.170
Why?
Positron-Emission Tomography
1
2009
35
0.170
Why?
Kyphosis
1
2009
9
0.170
Why?
Swine
1
2009
170
0.170
Why?
Patient Admission
1
2009
77
0.170
Why?
Respiration Disorders
1
2009
6
0.160
Why?
Blood Gas Monitoring, Transcutaneous
1
2009
10
0.160
Why?
Receptors, Notch
1
2009
50
0.160
Why?
Parathyroid Neoplasms
1
2009
13
0.160
Why?
Mediastinal Neoplasms
1
2009
21
0.160
Why?
Models, Animal
1
2009
131
0.160
Why?
Diffusion of Innovation
1
2008
21
0.160
Why?
Diagnosis, Differential
2
2004
855
0.150
Why?
Prevalence
4
2009
530
0.150
Why?
Forecasting
1
2008
172
0.150
Why?
Esophageal Stenosis
1
2007
14
0.150
Why?
Receptor, Epidermal Growth Factor
1
2008
90
0.150
Why?
Anoxia
1
2009
154
0.150
Why?
Antineoplastic Agents, Phytogenic
1
2007
38
0.150
Why?
Paclitaxel
1
2007
56
0.150
Why?
Biopsy, Needle
2
2003
144
0.140
Why?
DNA
1
2012
831
0.140
Why?
Quality of Life
1
2011
486
0.140
Why?
Gastrectomy
1
2007
10
0.140
Why?
Equipment Design
1
2008
244
0.140
Why?
Adolescent
5
1996
4513
0.140
Why?
Epithelial Cells
1
2008
324
0.130
Why?
Mediastinal Emphysema
1
2005
9
0.130
Why?
Injections, Intralesional
1
2005
12
0.130
Why?
Incidence
1
2008
644
0.130
Why?
Gastric Acidity Determination
1
2005
7
0.130
Why?
Young Adult
4
2009
1013
0.120
Why?
Wounds, Nonpenetrating
1
2005
69
0.120
Why?
Monitoring, Physiologic
1
2005
94
0.120
Why?
Evaluation Studies as Topic
1
2005
240
0.120
Why?
Pneumothorax
1
2004
23
0.120
Why?
Germinoma
1
2004
3
0.120
Why?
Hypertension, Pulmonary
1
2004
28
0.120
Why?
Mesothelioma
1
2004
30
0.120
Why?
Certification
1
2004
40
0.120
Why?
Pulmonary Emphysema
1
2004
34
0.120
Why?
Logistic Models
3
2010
581
0.110
Why?
Testicular Neoplasms
1
2004
52
0.110
Why?
Carcinoma, Squamous Cell
3
2009
230
0.110
Why?
Randomized Controlled Trials as Topic
1
2005
400
0.110
Why?
Tracheoesophageal Fistula
1
2002
6
0.100
Why?
Tracheostomy
1
2002
19
0.100
Why?
Surgical Flaps
1
2002
112
0.090
Why?
Signal Transduction
1
2009
1465
0.090
Why?
Kaplan-Meier Estimate
2
2010
190
0.090
Why?
Odds Ratio
2
2010
301
0.080
Why?
Child
2
1996
3897
0.080
Why?
Endoscopy, Digestive System
1
1998
9
0.080
Why?
Gene Expression Regulation
3
2007
848
0.080
Why?
Vagotomy
1
1997
11
0.070
Why?
Survival Rate
2
2009
584
0.070
Why?
Mucin-2
2
2007
5
0.070
Why?
Cell Line, Tumor
2
2009
543
0.070
Why?
Pneumonectomy
1
1996
13
0.070
Why?
Physical Fitness
1
1996
20
0.070
Why?
Cadaver
1
1996
85
0.070
Why?
Immunosuppression
1
1996
64
0.070
Why?
Tissue Donors
1
1996
69
0.070
Why?
New York
2
2009
1191
0.070
Why?
Cystic Fibrosis
1
1996
60
0.060
Why?
Graft Rejection
1
1996
142
0.060
Why?
Living Donors
1
1996
86
0.060
Why?
Tumor Cells, Cultured
2
2007
871
0.060
Why?
Reoperation
2
2002
182
0.060
Why?
Statistics, Nonparametric
2
2002
251
0.060
Why?
Animals
1
2009
15647
0.050
Why?
Clavicle
2
2002
19
0.050
Why?
Cell Line
2
2007
1554
0.050
Why?
Quality Improvement
1
2012
20
0.050
Why?
Neoplasm Grading
1
2011
8
0.050
Why?
Cell Differentiation
2
2007
1021
0.050
Why?
Esophageal Sphincter, Lower
1
2011
2
0.050
Why?
Spasm
1
2011
7
0.050
Why?
Infant, Newborn
1
1996
1772
0.050
Why?
Preoperative Period
1
2010
5
0.050
Why?
Tumor Stem Cell Assay
1
2010
22
0.050
Why?
Prospective Studies
2
2002
1606
0.040
Why?
SEER Program
1
2010
51
0.040
Why?
Vascular Neoplasms
1
2010
5
0.040
Why?
Granulocyte Colony-Stimulating Factor
1
2010
42
0.040
Why?
Dose Fractionation
1
2010
57
0.040
Why?
Child, Preschool
1
1996
2452
0.040
Why?
Remission Induction
1
2010
155
0.040
Why?
Mucous Membrane
1
2010
37
0.040
Why?
Translational Medical Research
1
2010
36
0.040
Why?
Cisplatin
1
2010
93
0.040
Why?
Databases, Factual
1
2010
147
0.040
Why?
Dipeptides
1
2009
15
0.040
Why?
Confidence Intervals
1
2010
155
0.040
Why?
Drug Administration Schedule
1
2010
362
0.040
Why?
Bone Diseases, Metabolic
1
2009
21
0.040
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2009
73
0.040
Why?
Hyperparathyroidism
1
2009
25
0.040
Why?
Referral and Consultation
1
2010
188
0.040
Why?
Combined Modality Therapy
1
2010
459
0.040
Why?
Pilot Projects
1
2010
426
0.040
Why?
Spinal Fractures
1
2009
34
0.040
Why?
Sex Factors
1
2010
561
0.040
Why?
World Health
1
2009
59
0.040
Why?
Photochemotherapy
1
2009
97
0.040
Why?
Cell Culture Techniques
1
2008
86
0.040
Why?
Biopsy
1
2009
359
0.040
Why?
Reference Values
1
2009
427
0.040
Why?
Recombinant Proteins
1
2010
706
0.040
Why?
Lymphocytes
1
2009
293
0.040
Why?
Cohort Studies
1
2011
912
0.040
Why?
Analysis of Variance
1
2010
705
0.040
Why?
Ligands
1
2008
287
0.040
Why?
Anastomosis, Roux-en-Y
1
2007
12
0.040
Why?
Catheterization
1
2007
122
0.040
Why?
Transcriptional Activation
1
2008
280
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
409
0.030
Why?
Treatment Failure
1
2007
125
0.030
Why?
Phosphorylation
1
2008
754
0.030
Why?
Chi-Square Distribution
1
2007
320
0.030
Why?
Reproducibility of Results
1
2009
859
0.030
Why?
Immunohistochemistry
1
2009
1024
0.030
Why?
Thoracostomy
1
2004
3
0.030
Why?
Pulmonary Artery
1
2004
78
0.030
Why?
United States
1
2010
2511
0.030
Why?
Risk Factors
1
2009
2172
0.030
Why?
Respiratory Distress Syndrome, Adult
1
2002
75
0.020
Why?
Respiration, Artificial
1
2002
170
0.020
Why?

Visualizations


Watson's Networks

Same Department